Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Invested Capital (2016 - 2025)

Historic Invested Capital for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $9.7 million.

  • Firefly Neuroscience's Invested Capital rose 44800.0% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 44800.0%. This contributed to the annual value of $452000.0 for FY2024, which is 31467.89% up from last year.
  • Latest data reveals that Firefly Neuroscience reported Invested Capital of $9.7 million as of Q3 2025, which was up 44800.0% from $12.6 million recorded in Q2 2025.
  • In the past 5 years, Firefly Neuroscience's Invested Capital registered a high of $17.4 million during Q4 2021, and its lowest value of -$2.8 million during Q3 2024.
  • Its 5-year average for Invested Capital is $5.4 million, with a median of $3.4 million in 2023.
  • Its Invested Capital has fluctuated over the past 5 years, first tumbled by 42556.82% in 2024, then skyrocketed by 147464.48% in 2025.
  • Quarter analysis of 5 years shows Firefly Neuroscience's Invested Capital stood at $17.4 million in 2021, then plummeted by 110.33% to -$1.8 million in 2022, then surged by 106.05% to $109000.0 in 2023, then surged by 314.68% to $452000.0 in 2024, then soared by 2036.5% to $9.7 million in 2025.
  • Its Invested Capital was $9.7 million in Q3 2025, compared to $12.6 million in Q2 2025 and $5.2 million in Q1 2025.